Correlation Between Aquestive Therapeutics and Unrivaled Brands
Can any of the company-specific risk be diversified away by investing in both Aquestive Therapeutics and Unrivaled Brands at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aquestive Therapeutics and Unrivaled Brands into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aquestive Therapeutics and Unrivaled Brands, you can compare the effects of market volatilities on Aquestive Therapeutics and Unrivaled Brands and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aquestive Therapeutics with a short position of Unrivaled Brands. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aquestive Therapeutics and Unrivaled Brands.
Diversification Opportunities for Aquestive Therapeutics and Unrivaled Brands
0.08 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Aquestive and Unrivaled is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Aquestive Therapeutics and Unrivaled Brands in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Unrivaled Brands and Aquestive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aquestive Therapeutics are associated (or correlated) with Unrivaled Brands. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Unrivaled Brands has no effect on the direction of Aquestive Therapeutics i.e., Aquestive Therapeutics and Unrivaled Brands go up and down completely randomly.
Pair Corralation between Aquestive Therapeutics and Unrivaled Brands
Given the investment horizon of 90 days Aquestive Therapeutics is expected to generate 0.89 times more return on investment than Unrivaled Brands. However, Aquestive Therapeutics is 1.12 times less risky than Unrivaled Brands. It trades about 0.1 of its potential returns per unit of risk. Unrivaled Brands is currently generating about 0.03 per unit of risk. If you would invest 86.00 in Aquestive Therapeutics on September 1, 2024 and sell it today you would earn a total of 423.00 from holding Aquestive Therapeutics or generate 491.86% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 24.84% |
| Values | Daily Returns |
Aquestive Therapeutics vs. Unrivaled Brands
Performance |
| Timeline |
| Aquestive Therapeutics |
| Unrivaled Brands |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Aquestive Therapeutics and Unrivaled Brands Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aquestive Therapeutics and Unrivaled Brands
The main advantage of trading using opposite Aquestive Therapeutics and Unrivaled Brands positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aquestive Therapeutics position performs unexpectedly, Unrivaled Brands can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Unrivaled Brands will offset losses from the drop in Unrivaled Brands' long position.| Aquestive Therapeutics vs. Evoke Pharma | Aquestive Therapeutics vs. Dynavax Technologies | Aquestive Therapeutics vs. Amphastar P | Aquestive Therapeutics vs. Lantheus Holdings |
| Unrivaled Brands vs. MPX International Corp | Unrivaled Brands vs. 4Front Ventures Corp | Unrivaled Brands vs. StateHouse Holdings | Unrivaled Brands vs. Decibel Cannabis |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |